Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled TrialLEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis VulgarisCervical Interlaminar Versus Transforaminal Epidural Steroid InjectionBetamethasone Dosing Interval - 12 or 24 Hours?Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"Caesarean and CorticotherapyEffectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity PainTreatment of Chronic Thoracic and Neck and Upper Extremity PainEfficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis VulgarisAmnion-Based Injections in the ShoulderLocal Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE StudyKIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAPEnstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of ColorComparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis TreatmentLEO 90100 in the Treatment of Psoriasis VulgarisLEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis VulgarisLEO 90105 Ointment in Japanese Subjects With PsoriasisA Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis VulgarisLumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque PsoriasisIndia Dexamethasone and BetamethasoneEffect of Antenatal Corticosteroids on Neonatal Morbidity.1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratEfficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/EczemaEffects of ACS in Twin With LPB: Study Protocol for a RCTA Clinical Trial Evaluating Efficacy and Safety of MC2-01 CreamClinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 CreamBetamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After TonsillectomyEvaluation of the Vasoconstriction Properties of MC2-01 CreamTo Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).Antenatal Betamethasone and the Risk of Neonatal HypoglycemiaComparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal ConditionsACTH vs Betamethasone in Hospitalized Patients With Acute GoutObservational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life
P4844
Q61864931-88101706-B388-4249-B9FD-AABB188B1F8FQ61894203-A918A730-1E71-4EFF-968B-7FB02D088D6EQ61908764-158E5F48-B155-44C3-9A4B-CFF8793B5BCEQ61920820-DE99A281-E5B0-460C-A02E-B15BBD99DC35Q61922203-1B6FE736-A790-4668-8225-354A9BB91073Q61924370-48A12898-E8B6-4AAD-8B4B-3EA9EFF738C7Q61933264-2E9D7A24-0EBE-40C2-9E84-CB5737F7821BQ61938698-7FED939B-5FB8-4F75-9C38-456860CC3149Q61955754-DAD791EB-8813-479E-909B-43801ABFB3A3Q61956321-E69CCC10-EC2D-4C57-83B6-A8F795B558ABQ62031385-B81F4C92-6F4D-43E7-8140-1BC64A514079Q62031664-FEC65095-6C1C-4426-8CAA-D859A45C15E9Q62042628-D8546946-1649-47D3-861A-E607A4419114Q62814227-FCC3DF3F-36E4-4879-BC0E-A633D626784FQ62822961-069F58B2-7FF6-41CD-8EAC-EAC7048E7CC4Q63317533-4424BE8C-9CBC-4134-9AE2-29C7C0150C3DQ63319898-077D1C12-866B-4D21-8F39-BF2A41F7A271Q63320207-9565747C-9252-4C71-97C6-3828249A311CQ63321889-BB798EE6-C9F6-47CF-BA1D-033C0F058329Q63335827-1E4F42EF-0879-4137-BD23-2C376A22369EQ63340469-FD76FB48-1DB3-4574-B604-D0EE5253958FQ63392861-CB0F564E-B441-4BE7-9618-3BCA6B029DEEQ63392975-A15A309E-E783-4C30-B57D-2476ADB5C6E9Q63401647-7D11DC2B-4D46-4CBD-8992-B65C02DCBF25Q63402398-1B77B0A7-ABE6-48F6-9018-ABA2195E57D2Q63403953-C5321C53-6C9C-48F9-92DA-9D9EB64D9AC1Q63571801-43EF2D31-A0B3-4568-B6F3-49523EFFECD3Q63572384-FF6F58FD-5EBD-4AF8-BAA6-D01E9D3A2A7FQ63579536-D90B8FBB-0CC5-42C8-A6A9-B9DD700C08E0Q63585512-AFA3A2BE-141C-4A7F-BB86-0D7952358280Q63592924-9839E306-2056-4D93-8F70-8CFB5340B4BFQ63593008-AF8C4543-C062-4BC1-A315-5CBCE982FC48Q63595903-EF8EC0BD-E92D-4556-AE69-44E933B06848Q63596549-2107F78B-43AC-4789-A522-B94BC4714D50Q86285973-CD675F65-EE7F-4EC7-AEC3-FFBE75F153D9Q87930711-2BEB6919-4C96-4B21-BD73-2E262676216EQ93704409-9172016C-90E2-4719-B68D-47502B9918C3
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
betamethasone sodium phosphate
@en
type
label
betamethasone sodium phosphate
@en
altLabel
9-Fluoro-11beta,17,21-trihydro ...... -dione 21-(disodium phosphate)
@en
Betamethasone 21-disodium phosphate
@en
Betamethazone disodium phosphate
@en
prefLabel
betamethasone sodium phosphate
@en
P486
P592
P661
P662
P665
P683
P2017
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(= ...... O-])[O-])O)C)O)F)C.[Na+].[Na+]
P2067
P2115
N0000146959
P231
P232
P233
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]
P234
1S/C22H30FO8P.2Na/c1-12-8-16-1 ...... ,17-,19-,20-,21-,22-;;/m0../s1
P235
PLCQGRYPOISRTQ-LWCNAHDDSA-L
P2566
100.005.271
P274
C₂₂H₂₈FNa₂O₈P